UNSPSC 51282938: Pipemidic acid

This classification denotes a urinary anti-infective agent and quinolone antibiotic with the molecular formula C14H17N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LT12J5HVR8, chemically known as 5,8-dihydro-8-ethyl-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-carboxylic acid but generally known as pipemidic acid, which bears US NIH Compound Identifier 4831. European Medicines Agency schedules Pipemidic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09863MIG.

UNSPSC 51282938 Pipemidic acid is a Commodity code that in recent state and local procurement shows little activity aligned to its nominal pharmaceutical ingredient scope. The three recent opportunities posted under this code are actually soliciting naloxone and drug deactivation systems (Seminole County, Florida), generic multi-source pharmaceuticals and OTC products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance), medical and first aid supplies for fire rescue (City of Tampa), and direct-to-manufacturer prescription fulfillment capabilities (Texas Health and Human Services Commission). None of these solicitations concern pipemidic acid specifically, suggesting either a tagging misalignment in the state and local procurement systems or that this code does not currently reflect active purchasing for the named ingredient at the state and local level.

The issuing bodies span county health departments, state cooperative purchasing programs, municipal fire services, and state health agencies across Florida, Minnesota, Texas, and Oregon. The representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems with quarterly deliveries through June 2026; the City of Tampa's IFB for medical and first aid supplies estimated at $700,000.00, designated as a sheltered market procurement for certified Small Local Business Enterprises and due March 13, 2026; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic pharmaceuticals and OTC products due March 26, 2026, and effective July 1, 2026. Given the mismatch between the code's nominal scope and the actual work being solicited, this code warrants monitoring for either corrected tagging or clarification of whether pipemidic acid procurement occurs under different codes in state and local systems.